Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
aforementioned, American, animal, appeal, back, BioDelivery, career, Central, Chair, Chairperson, client, CMO, conclusion, construct, contest, Deloitte, disagreement, doubling, ESPP, Exhibit, expertise, family, fill, Florida, Fortune, hamster, hearing, hereto, hinder, inability, Institute, interval, Isicrate, journal, Karen, lapsed, Leader, listing, Marketplace, Marquette, Medicine, medRxiv, member, middle, mixture, Nasdaq, Omicron, parental, path, Paul, pharmaceutical, predecessor, proposed, qualified, reached, recommendation, Regulation, reject, resign, resignation, Restated, revert, Robert, science, Secretary, shifted, shorter, slightly, sooner, spent, Stipulation, successor, thereof, Tohmatsu, Touche, Translational, trending, undergraduate, unpaid, vacancy, variant, vigorously, Watson, Wilson, Yedid, younger
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view